For this brand new episode of Finding the Front we are so fortunate to have biotech and life sciences veteran Matt Callahan on the show. Matt is a Philadelphia based, Australian born life sciences entrepreneur, with a track record of building and exiting numerous life sciences companies in pain, oncology, dermatology, cell therapies, animal health and regenerative medicine.

He starts the show off on the front foot answering the question of Donald Trumps impact going forward on the US Biotech and Life Science sector showcasing his thoughts for aspiring investors.

Matt has accumulated 25 years legal, life sciences, IP and investment management experience and is founder and executive director of ASX listed Botanix Pharmaceuticals, co-founder and director of Respirion Pharmaceuticals Pty Ltd and was also a co-founder of life science companies Dimerix Bioscience Ltd, Mirata Pharmaceuticals LLC and Orthocell Ltd, as well as the Bill Gates backed climate tech company, Rumin8 Pty Ltd.

Matt is such a great communicator and provides some deep insights into being an entrepreneur, the world of life sciences, FDA approval, the phases of a company and distribution. This really is a captivating chat.

To request a Euroz Hartleys team member to contact you or if you have some feedback on the podcast please click here

Please follow us and stay up to date with Euroz Hartleys on LinkedIn

To be added to the podcast “new release” email distribution list please click here

Matt Callahan, Founder & Executive Director of Botanix Pharmaceuticals